Back to Search
Start Over
Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024
- Source :
- Plus Company Updates. November 8, 2024
- Publication Year :
- 2024
-
Abstract
- SPRING HOUSE: Johnson & Johnson has issued the following news release: Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.815316891